143 related articles for article (PubMed ID: 2308143)
1. Selective inhibition of gamma-aminobutyric acid aminotransferase by (3R,4R),(3S,4S)- and (3R,4S),(3S,4R)-4-amino-5-fluoro-3-phenylpentanoic acids.
Silverman RB; Nanavati SM
J Med Chem; 1990 Mar; 33(3):931-6. PubMed ID: 2308143
[TBL] [Abstract][Full Text] [Related]
2. 4-Amino-2-(substituted methyl)-2-butenoic acids: substrates and potent inhibitors of gamma-aminobutyric acid aminotransferase.
Silverman RB; Durkee SC; Invergo BJ
J Med Chem; 1986 May; 29(5):764-70. PubMed ID: 3701787
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of gamma-aminobutyric acid aminotransferase by (S,E)-4-amino-5-fluoropent-2-enoic acid and effect on the enzyme of (E)-3-(1-aminocyclopropyl)-2-propenoic acid.
Silverman RB; Invergo BJ; Mathew J
J Med Chem; 1986 Oct; 29(10):1840-6. PubMed ID: 3761305
[TBL] [Abstract][Full Text] [Related]
4. Inhibition and substrate activity of conformationally rigid vigabatrin analogues with gamma-aminobutyric acid aminotransferase.
Qiu J; Pingsterhaus JM; Silverman RB
J Med Chem; 1999 Nov; 42(22):4725-8. PubMed ID: 10579835
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of inactivation of gamma-aminobutyric acid-alpha-ketoglutaric acid aminotransferase by 4-amino-5-halopentanoic acids.
Silverman RB; Levy MA
Biochemistry; 1981 Mar; 20(5):1197-203. PubMed ID: 7225323
[TBL] [Abstract][Full Text] [Related]
6. A new class of conformationally rigid analogues of 4-amino-5-halopentanoic acids, potent inactivators of gamma-aminobutyric acid aminotransferase.
Qiu J; Silverman RB
J Med Chem; 2000 Feb; 43(4):706-20. PubMed ID: 10691696
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo effects on brain GABA metabolism of (S)-4-amino-5-fluoropentanoic acid, a mechanism-based inactivator of gamma-aminobutyric acid transaminase.
Silverman RB; Muztar AJ; Levy MA; Hirsch JD
Life Sci; 1983 Jun; 32(24):2717-23. PubMed ID: 6855467
[TBL] [Abstract][Full Text] [Related]
8. Structural modifications of (1S,3S)-3-amino-4-difluoromethylenecyclopentanecarboxylic acid, a potent irreversible inhibitor of GABA aminotransferase.
Yuan H; Silverman RB
Bioorg Med Chem Lett; 2007 Mar; 17(6):1651-4. PubMed ID: 17267220
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic crystallography. Mechanism of inactivation of gamma-aminobutyric acid aminotransferase by (1R,3S,4S)-3-amino-4-fluorocyclopentane-1-carboxylic acid as elucidated by crystallography.
Storici P; Qiu J; Schirmer T; Silverman RB
Biochemistry; 2004 Nov; 43(44):14057-63. PubMed ID: 15518554
[TBL] [Abstract][Full Text] [Related]
10. Mechanism-based inactivation of gamma-aminobutyric acid aminotransferase by 3-amino-4-fluorobutanoic acid.
Silverman RB; Roscher CL
Bioorg Med Chem; 1996 Sep; 4(9):1521-35. PubMed ID: 8894109
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of inactivation of gamma-aminobutyric acid aminotransferase by (S,E)-4-amino-5-fluoropent-2-enoic acid.
Silverman RB; George C
Biochem Biophys Res Commun; 1988 Feb; 150(3):942-6. PubMed ID: 3342072
[TBL] [Abstract][Full Text] [Related]
12. On the inhibition of glutamic acid decarboxylase and gamma-aminobutyric acid transaminase by sodium cyanide.
Cassel G; Karlsson L; Sellström A
Pharmacol Toxicol; 1991 Oct; 69(4):238-41. PubMed ID: 1956876
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of gamma-aminobutyric acid aminotransferase by (Z)-4-amino-2-fluorobut-2-enoic acid.
Silverman RB; George C
Biochemistry; 1988 May; 27(9):3285-9. PubMed ID: 3390432
[TBL] [Abstract][Full Text] [Related]
14. Active site model for gamma-aminobutyrate aminotransferase explains substrate specificity and inhibitor reactivities.
Toney MD; Pascarella S; De Biase D
Protein Sci; 1995 Nov; 4(11):2366-74. PubMed ID: 8563634
[TBL] [Abstract][Full Text] [Related]
15. Beta-lactams: a new class of conformationally-rigid inhibitors of gamma-aminobutyric acid aminotransferase.
Hopkins MH; Silverman RB
J Enzyme Inhib; 1992; 6(2):125-9. PubMed ID: 1284428
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of inactivation of gamma-aminobutyrate aminotransferase by 4-amino-5-fluoropentanoic acid. First example of an enamine mechanism for a gamma-amino acid with a partition ratio of 0.
Silverman RB; Invergo BJ
Biochemistry; 1986 Nov; 25(22):6817-20. PubMed ID: 3801394
[TBL] [Abstract][Full Text] [Related]
17. In vivo action of enzyme-activated irreversible inhibitors of glutamic acid decarboxylase and gamma-aminobutyric acid transaminase in retina vs. brain.
Cubells JF; Blanchard JS; Smith DM; Makman MH
J Pharmacol Exp Ther; 1986 Aug; 238(2):508-14. PubMed ID: 3735130
[TBL] [Abstract][Full Text] [Related]
18. Rational Design, Synthesis, and Mechanism of (3
Zhu W; Butrin A; Melani RD; Doubleday PF; Ferreira GM; Tavares MT; Habeeb Mohammad TS; Beaupre BA; Kelleher NL; Moran GR; Liu D; Silverman RB
J Am Chem Soc; 2022 Mar; 144(12):5629-5642. PubMed ID: 35293728
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of analogues of the carboxyl protease inhibitor pepstatin. Effects of structure on inhibition of pepsin and renin.
Rich DH; Sun ET; Ulm E
J Med Chem; 1980 Jan; 23(1):27-33. PubMed ID: 6767029
[TBL] [Abstract][Full Text] [Related]
20. Structural and Mechanistic Basis for the Inactivation of Human Ornithine Aminotransferase by (3
Shen S; Butrin A; Beaupre BA; Ferreira GM; Doubleday PF; Grass DH; Zhu W; Kelleher NL; Moran GR; Liu D; Silverman RB
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
